Molecular therapies and vaccines face the challenges of emerging infectious diseases
Mol Ther
.
2022 May 4;30(5):1789-1790.
doi: 10.1016/j.ymthe.2022.04.003.
Epub 2022 Apr 16.
Authors
Ami Patel
1
,
David Weiner
2
,
Weidong Xiao
3
,
Andrew Baker
4
,
Niek Sanders
5
Affiliations
1
The Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: apatel@wistar.org.
2
The Wistar Institute, Philadelphia, PA 19104, USA.
3
Indiana University School of Medicine, Indianapolis, IN 46202-3082, USA.
4
The University of Edinburgh, Edinburgh EH16 4TJ, UK.
5
University of Ghent, Merelbeke, 9820 Merelbeke, Belgium.
PMID:
35429438
PMCID:
PMC9012659
DOI:
10.1016/j.ymthe.2022.04.003
No abstract available
Publication types
Editorial
MeSH terms
Communicable Diseases, Emerging* / prevention & control
Humans
Vaccines*
Substances
Vaccines